The Texas Health and Human Services Commission (HHSC) has retained Magellan Medicaid Administration to provide Preferred Drug List (PDL) development and management and Supplemental Rebate contracting services. Provider Synergies, LLC is an affiliate of Magellan Medicaid Administration, and became a wholly-owned subsidiary of Magellan Health Services in 2009.
Magellan Medicaid Administration provides HHSC and the Texas Drug Utilization Review (DUR) Board with independent and thorough review and analysis of published, peer-reviewed data regarding the relative safety and efficacy of drug products within a given Therapeutic Drug Class. Combining this clinical data with cost information, Magellan Medicaid Administration makes a determination of the value of each drug within the Class. This information is among that considered by the DUR Board in developing its PDL recommendations to HHSC.
Information regarding the Texas Drug Utilization Review (DUR) Board, along with the current Texas Medicaid PDL, can be found here.
Upcoming Product Review Information
Texas Medicaid Conditions of Participation
Request for Offers
Participation in the Supplemental Rebate Process for Texas Medicaid
The Offer Form provides the mechanism for you to submit your proposals for the Supplemental Rebate program.
Once your company has provided contact information to Provider Synergies, your company's designated representatives will be notified when one or more of your products are under consideration for the PDL.
Line Extension Form
The Line Extension Form provides the mechanism for your company to submit line extensions for the Supplemental Rebate program.
For questions about the PDL, please contact Provider Synergies at 513-774-8500.